Urgent monitoring of dabigatran plasma levels: Sometimes less is more

Polskie Archiwum Medycyny Wewnetrznej

Volumn 124, Issue 11, 2014, Pages 639-640

  Lippi, Giuseppe ^a,c   Favaloro, Emmanuel J ^a,b  

^a ACADEMIC HOSPITAL OF PARMA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; LUPUS ANTICOAGULANT; THROMBIN; VENOM; ANTICOAGULANT AGENT; ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE;

ALGORITHM; BLOOD CLOTTING TEST; DABOIA RUSSELLII; DRUG BLOOD LEVEL; DRUG MONITORING; HUMAN; LETTER; LIQUID CHROMATOGRAPHY; PARTIAL THROMBOPLASTIN TIME; TANDEM MASS SPECTROMETRY; THROMBIN TIME; TURNAROUND TIME; BLOOD;

ANTICOAGULANTS; ANTITHROMBINS; BENZIMIDAZOLES; BETA-ALANINE; DABIGATRAN; HUMANS;

EID: 84916892355     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2509     Document Type: Letter

References (5)

1. Czubek U, Góralczyk T, Zalewski J, Undas A. Monitoring of anticoagulant effects of dabigatran in everyday practice: first experience in 32 Polish patients. Pol Arch Med Wewn. 2014; 124: 553-555.
2. Harenberg J, Kraemer S, Du S, et al. Determination of direct oral anticoagulants from human serum samples. Semin Thromb Hemost. 2014; 40: 129-134.
3. Lippi G, Favaloro EJ. Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): Is there consensus? Clin Chem Lab Med. 2014. 2014 Sep 22. [Epub ahead of print].
4. Lippi G, Ardissino D, Quintavalla R, Cervellin G. Urgent monitoring of direct oral anticoagulants in patients with atrial fibrillation: a tentative approach based on routine laboratory tests. J Thromb Thrombolysis. 2014; 38: 269-274.
5. Favaloro EJ, Lippi G. The new oral anticoagulants and the future of haemostasis laboratory testing. Biochem Med (Zagreb). 2012; 22: 329-341.